Speciality: Oncology
Description:
A warm welcome to all the medical professionals in this exciting learning session on managing Ph negative Acute lymphoblastic leukemia in adults.
Acute Lymphoblastic Leukemia (ALL) is a cancer of the blood and bone marrow that progresses rapidly without treatment. It can reoccur after being in remission from previous treatment. It has been noted that refractory ALL did not respond to treatment indicating the previous treatments did not kill enough leukemia cells (blasts) to reach complete remission.
Ph-positive ALL is a special type of ALL in which a genetic mutation is observed in the Philadelphia chromosome. In the case of Ph-negative ALL, genetic disparities are also observed and most importantly in Ph neg ALL there is a disproportionate survival rate among the patients.
Managing Ph neg ALL often becomes difficult, however, the procedures of management of Philadelphia chromosome (Ph)–negative acute lymphoblastic leukemia (ALL) have changed dramatically in recent years leading to a positive vibe for the situation.
Therefore, have overall knowledge regarding the management of Ph negative ALL. Listen to the webinar, grab the knowledge that is shared and follow HiDoc for more such interesting webinar sessions.
See More Webinars @ Hidoc Webinars
1.
Le cancer et le COVID ont conduit le patient à une double transplantation de poumon.
2.
FDA Greenlights First Engineered Cell Therapy for a Solid Tumor
3.
The FDA Approves the New Frontline Aggressive ALL Regimen.
4.
Studies point to redlining as a 'perfect storm' for breast cancer
5.
Targeted radiation therapy shows near-complete response in rare sarcoma patients
1.
The Power of Salt Tablets: Unlocking Health Benefits Beyond Sodium
2.
Neuroendocrine Tumors: Mechanisms of Mortality, Associated Conditions
3.
Revolutionizing Thyroid Cancer: Advances in Molecular Genetics and Personalized Treatment Approaches
4.
Seeing the Unseen: The Benefits of Early Stage Breast Cancer Ultrasound
5.
Unlocking the Secrets of Follicular Cells: Exploring the Potential of Stem Cell Research
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
International Lung Cancer Congress®
3.
Genito-Urinary Oncology Summit 2026
4.
Future NRG Oncology Meeting
5.
ISMB 2026 (Intelligent Systems for Molecular Biology)
1.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
2.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III
3.
Redefining Treatment Pathways in Relapsed/Refractory Adult B-Cell ALL
4.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation